Robert J. Brown, M.D. joined Zai Lab in September 2023 as Chief Medical Officer, Oncology.
Dr. Brown is an oncology drug development leader, with more than 16 years of translational, research, and clinical development expertise in the areas of oncology, immunology, and neurology.
Dr. Brown joined Zai Lab from Nurix Therapeutics where he held various clinical development roles of increasing responsibility, most recently he served as Executive Vice President, Clinical Development. Prior to Nurix, he led clinical development programs for a wide variety of products in the areas of oncology, immunology, and neurology for companies including Allogene Therapeutics, Aduro Biotech, and Iovance Biotherapeutics.
In addition to his drug development expertise, Dr. Brown is a trained pediatric oncologist and neuro-oncologist, having served as a physician at Yale University, the City of Hope National Medical Center, and the Children’s Hospital Los Angeles as well as in academic roles at the University of Southern California and the University of California Los Angeles.
Dr. Brown received an M.D. from the Weill Cornell Medical College in New York and a B.S. in Chemistry from the Massachusetts Institute of Technology.
